Integrated CMC Solutions

Almac addresses the growing industry need to develop & manufacture clinical candidates faster by providing an integrated CMC solution, bridging the gap between drug substance and drug product development.

By offering these services within an integrated package, our client partners are assured of scientific continuity from a dedicated project team, from a single source, resulting in significant savings in both time and costs.

Integrated teams within Chemical and Pharmaceutical Development work closely together to fully understand the physicochemical properties of the API to ensure the optimum chemical entity is available for the manufacture of clinical supplies. We routinely apply our innovative biocatalysis technology solutions, which are beyond the traditional realms of chemical synthesis and provides new and attractive synthesis options which are fully scalable, safe and economic.

Whether your requirements are for First in Human supplies or later phase development, manufacture or registration batches, Almac has access to a wide range of innovative technologies for both potent and non-potent solid oral dose products. 

Having both chemical and pharmaceutical development operations at the same campus allows for optimal communication and knowledge transfer on projects.  Our clients leverage this integrated service offering, exploiting the Almac advantage of a single partner approach.  Smoothing transition through the drug development process and ultimately commercialisation saves time, transfers and other uncertainties inherent in a multi-supplier, multi-site process.